TriSalus Life Sciences (TLSI) Inventory Average (2023 - 2026)

TriSalus Life Sciences has reported Inventory Average for 4 years, with the latest figure at $3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 16.5% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (down 16.5% YoY), and the FY2025 full-year result was $3.6 million, up 8.07% from the prior year.
• Inventory Average for Q1 2026 stood at $3.4 million, up from $3.2 million in the prior quarter.
• The five-year high for Inventory Average was $4.1 million in Q1 2025, with the low at $2.1 million in Q4 2023.
• Historically, Inventory Average has averaged $3.4 million across 4 years, with a median of $3.5 million in 2025.
• Annual changes were most pronounced in 2024 — Inventory Average surged 92.79% — and 2025, when it declined 21.05%.
• TriSalus Life Sciences' Inventory Average stood at $2.1 million in 2023, then jumped by 92.79% to $4.0 million in 2024, then decreased by 21.05% to $3.2 million in 2025, then grew by 7.9% to $3.4 million in 2026.
• The last three Inventory Average figures came in at $3.4 million (Q1 2026), $3.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.